AbbVie Inc. News

California Department of Insurance Fraud Suit Results in $24M in Payments from AbbVie

California Insurance Commissioner Ricardo Lara this week announced a settlement agreement with AbbVie Inc. to resolve a lawsuit alleging violations of the California Insurance Frauds Prevention Act involving the marketing of blockbuster prescription drug HUMIRA. AbbVie agreed to reform its …

California Commissioner Sues Biopharma Giant AbbVie Alleging Illegal Kickbacks in Promoting HUMIRA

California Insurance Commissioner Dave Jones on Tuesday filed an insurance-fraud complaint in Alameda County Superior Court on behalf of the state against AbbVie Inc. alleging the company gave illegal kickbacks to healthcare providers to prescribe HUMIRA, which Jones classified as …

Jury Orders AndroGel Maker AbbVie to Pay $3M After Judge Rejected $150M

A U.S. jury on Monday ordered AbbVie Inc. to pay more than $3 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, though the jury …

Jury Orders Punitive, but No Compensatory, Damages in AbbVie Drug Liability Test Trial

A federal jury in Chicago on Monday found AbbVie Inc. fraudulently misrepresented the risks of its testosterone replacement drug AndroGel and ordered the drugmaker to pay $150 million in punitive damages. The verdict, which came in response to a lawsuit …

Illinois Jury: AbbVie Must Pay $15M in Depakote Birth-Defect Case

A federal jury in East St. Louis, Ill., has awarded $15 million to a 10-year-old boy whose mother blamed his birth defect on AbbVie Inc.’s bipolar disorder drug Depakote that she took while pregnant, in the latest trial among hundreds …